Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
14.14
Dollar change
-0.52
Percentage change
-3.55
%
Index- P/E- EPS (ttm)-11.62 Insider Own27.90% Shs Outstand20.75M Perf Week-4.14%
Market Cap293.41M Forward P/E- EPS next Y-5.52 Insider Trans4.14% Shs Float14.97M Perf Month-28.22%
Income-117.17M PEG- EPS next Q-1.41 Inst Own33.27% Short Float4.33% Perf Quarter87.78%
Sales3.60M P/S81.50 EPS this Y48.81% Inst Trans- Short Ratio2.62 Perf Half Y-15.33%
Book/sh8.23 P/B1.72 EPS next Y7.02% ROA-48.68% Short Interest0.65M Perf Year76.75%
Cash/sh4.65 P/C3.04 EPS next 5Y- ROE-88.43% 52W Range6.81 - 29.70 Perf YTD87.83%
Dividend Est.- P/FCF- EPS past 5Y0.36% ROI-79.11% 52W High-52.39% Beta0.83
Dividend TTM- Quick Ratio4.13 Sales past 5Y-56.90% Gross Margin-249.44% 52W Low107.64% ATR (14)1.93
Dividend Ex-Date- Current Ratio4.13 EPS Y/Y TTM25.38% Oper. Margin-3438.64% RSI (14)38.44 Volatility11.00% 10.37%
Employees121 Debt/Eq0.90 Sales Y/Y TTM-100.00% Profit Margin-3254.58% Recom1.33 Target Price40.00
Option/ShortYes / Yes LT Debt/Eq0.77 EPS Q/Q28.49% Payout- Rel Volume0.44 Prev Close14.66
Sales Surprise- EPS Surprise31.52% Sales Q/Q- EarningsMar 18 AMC Avg Volume247.21K Price14.14
SMA20-18.45% SMA50-14.52% SMA200-0.08% Trades Volume109,878 Change-3.55%
Date Action Analyst Rating Change Price Target Change
Jul-07-22Upgrade Truist Hold → Buy $4
Jul-23-21Downgrade Cantor Fitzgerald Overweight → Neutral
May-03-21Downgrade SVB Leerink Outperform → Mkt Perform $5
Apr-29-21Downgrade Truist Buy → Hold $30 → $9
Apr-29-21Downgrade RBC Capital Mkts Outperform → Sector Perform $6
Apr-29-21Downgrade Chardan Capital Markets Buy → Neutral $5
Dec-16-20Initiated UBS Neutral $13
Nov-12-20Upgrade Raymond James Underperform → Mkt Perform
Jun-26-20Downgrade Raymond James Mkt Perform → Underperform
May-13-20Initiated RBC Capital Mkts Outperform $24
Mar-27-24 09:35AM
Mar-21-24 07:52AM
Mar-20-24 05:33AM
Mar-19-24 09:40AM
Mar-18-24 10:53PM
04:20PM Loading…
04:20PM
04:05PM
Mar-06-24 03:07PM
Feb-28-24 04:05PM
Feb-27-24 06:10AM
Feb-22-24 06:15AM
Feb-12-24 08:00AM
Feb-08-24 07:00AM
Feb-05-24 07:45AM
Feb-01-24 05:30PM
08:00AM Loading…
Jan-29-24 08:00AM
Jan-04-24 08:27AM
Dec-07-23 04:05PM
Nov-28-23 04:05PM
Nov-09-23 04:51PM
04:05PM
Nov-06-23 08:00AM
Nov-04-23 05:54PM
Oct-24-23 12:30PM
Sep-26-23 04:05PM
Sep-21-23 04:05PM
Sep-05-23 04:05PM
Aug-21-23 04:05PM
Aug-14-23 08:00AM
Aug-10-23 04:20PM
04:05PM Loading…
04:05PM
Jun-12-23 08:00AM
Jun-02-23 08:00AM
May-25-23 06:30AM
May-18-23 09:00AM
09:00AM
May-11-23 04:47PM
04:05PM
May-10-23 04:05PM
May-02-23 04:30PM
Apr-23-23 01:00PM
Apr-21-23 06:03AM
Apr-18-23 08:00AM
Apr-17-23 04:05PM
Apr-04-23 09:40AM
Mar-30-23 04:05PM
Mar-02-23 10:23AM
Feb-27-23 04:05PM
Jan-18-23 04:05PM
Dec-06-22 04:05PM
Nov-10-22 04:05PM
Nov-04-22 12:08PM
Oct-27-22 04:05PM
Sep-30-22 04:45PM
Sep-27-22 04:05PM
Sep-23-22 04:05PM
11:06AM
08:00AM
Sep-15-22 05:19PM
Sep-14-22 08:00AM
Sep-08-22 04:05PM
Aug-26-22 04:05PM
Aug-11-22 04:05PM
Aug-10-22 04:05PM
Aug-01-22 04:05PM
Jul-25-22 07:16AM
Jul-15-22 09:52AM
08:32AM
Jul-08-22 08:00AM
Jul-07-22 05:14PM
11:22AM
08:02AM
Jul-06-22 04:05PM
09:31AM
Jun-24-22 08:00AM
Jun-09-22 08:00AM
Jun-02-22 04:05PM
May-19-22 08:00AM
May-18-22 08:11AM
May-17-22 04:05PM
May-12-22 04:05PM
May-11-22 02:51PM
May-09-22 04:05PM
May-02-22 04:30PM
06:59AM
May-01-22 02:15PM
Apr-19-22 06:00PM
Apr-07-22 02:50PM
07:30AM
Apr-06-22 04:05PM
Mar-29-22 04:05PM
Mar-17-22 04:05PM
Mar-02-22 12:11PM
Feb-28-22 08:00AM
Feb-15-22 04:22AM
Feb-07-22 04:05PM
Jan-06-22 04:05PM
Jan-04-22 08:00AM
Jan-01-22 06:02AM
Dec-21-21 12:42PM
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lupher, Jr. Mark L.DirectorFeb 07 '24Buy1.35130,000175,500130,000Feb 09 05:50 PM
Scopa James PaulDirectorFeb 07 '24Buy1.35100,000135,000100,000Feb 09 05:51 PM
Seyedkazemi SetarehChief Development OfficerSep 15 '23Sale1.526,2019,42947,674Sep 18 06:54 PM
Rubinstein Linda MChief Financial OfficerJun 07 '23Buy1.45100,000145,490100,000Jun 09 04:26 PM